Moderators: Dmitry Zamarin, MD & Michaela Onstad-Grinsfelder, MD

Presentations:

• Circulating cell-free (cf)DNA analysis: current technologies and applications in (gynecologic) cancer (Britta Weigelt, MD)
• Post-Surgical ctDNA-based Molecular Residual Disease Detection in Patients with Stage I Endometrial Cancer (Fernando Recio, MD)
• Feasibility of circulating tumor DNA as a marker for treatment response and prognosis in in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01) (Kyunghee Yu, MD)
• Exploring the utility of liquid biopsy (ctDNA) as a translational endpoint in clinical trials for endometrial cancer (Pamela Soliman, MD)